Get 20% lifetime commission for referring investors to digrin.com
here.
Definium Therapeutics, Inc. (DFTX) Financials
DFTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 1.1 billion | 194.2 million |
| March 31, 2026 | 401.3 million | 122.4 million |
| Dec. 31, 2025 | 440.1 million | 107.8 million |
| Sept. 30, 2025 | 236.9 million | 106.3 million |
DFTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -52.8 million | 9.6 million |
| March 31, 2026 | -42.6 million | 7.1 million |
| Dec. 31, 2025 | -41.9 million | 11.4 million |
| Sept. 30, 2025 | -29.6 million | 5.8 million |
DFTX Net Income
No data available :(
DFTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.1 billion | 36.5 million | - |
| March 31, 2026 | 373.4 million | - | - |
| Dec. 31, 2025 | 411.6 million | - | - |
| Sept. 30, 2025 | 209.1 million | 40.4 million | - |
DFTX Shares Outstanding
DFTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 48.7 million | 26.4 million | - |
| March 31, 2026 | - | 41.5 million | 17.7 million | - |
| Dec. 31, 2025 | - | 33.5 million | 14.1 million | - |
| Sept. 30, 2025 | - | 31.0 million | 14.7 million | - |
DFTX Cost of Revenue
No data available :(
DFTX
Price: $45.26
52 week price:
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 4.8 billion